CenterBook Partners LP Takes Position in Herbalife Ltd $HLF

CenterBook Partners LP bought a new position in shares of Herbalife Ltd (NYSE:HLF) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 43,550 shares of the company’s stock, valued at approximately $368,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Y Intercept Hong Kong Ltd purchased a new position in Herbalife during the 2nd quarter valued at approximately $531,000. Fund 1 Investments LLC bought a new position in shares of Herbalife during the 2nd quarter valued at approximately $8,491,000. Optimize Financial Inc purchased a new position in shares of Herbalife in the third quarter valued at $511,000. Iridian Asset Management LLC CT increased its position in Herbalife by 9.9% in the third quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company’s stock worth $20,671,000 after purchasing an additional 220,896 shares during the last quarter. Finally, Hussman Strategic Advisors Inc. purchased a new stake in Herbalife during the third quarter valued at $532,000.

More Herbalife News

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Cristiano Ronaldo purchased a disclosed minority stake (reported as ~10% of the Pro2col unit), which investors have treated as a credibility and growth signal for Herbalife’s wellness/tech spinout. Cristiano Ronaldo Invests $7.5 Million Into Herbalife—Stock Surges
• Positive Sentiment: Q4 revenue (≈$1.28–1.30B) topped consensus and the company issued FY/quarter guidance in line with or slightly above Street expectations — supporting the view that top-line growth is intact. Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
• Positive Sentiment: Analysts and quant-rank services turned more constructive: Maxim reiterated a Buy and Zacks added HLF to its Rank #1 (Strong Buy) lists, boosting short-term demand from retail and model-driven funds. Buy Rating on Herbalife Driven by Turnaround Momentum… New Strong Buy Stocks for February 20th
• Positive Sentiment: Shares hit a 52-week / multi-year high on the combined impact of the deal news, better-than-expected net sales and increased volume — momentum that can attract momentum/trend traders. Herbalife (HLF) Climbs to 3-Year High on Net Sales Beat
• Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for investors who want detailed color on product innovation, distributor trends and digital personalization initiatives — useful for modeling longer-term growth but not an immediate catalyst by itself. Herbalife Q4 2025 earnings call transcript
• Negative Sentiment: Mixed profitability signals: while revenue and operating cash flow grew, reported EPS metrics missed some consensus figures and the company showed year-over-year declines in operating profit and net income, which raises questions about margin recovery. Herbalife Ltd. (HLF) stock rises on Q4 2025 Earnings
• Negative Sentiment: Some outlets flagged an EPS miss versus consensus and a negative ROE / thin net margin — fundamentals investors watch for sustained valuation support. Herbalife Ltd (HLF) Misses Q4 Earnings and Revenue Estimates

Analyst Ratings Changes

Several brokerages have recently issued reports on HLF. Wall Street Zen upgraded shares of Herbalife from a “hold” rating to a “buy” rating in a research report on Friday, November 28th. Argus set a $15.00 price objective on Herbalife in a research note on Wednesday, November 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Herbalife in a research note on Thursday, January 22nd. Citigroup reiterated a “buy” rating and issued a $21.00 target price (up previously from $17.00) on shares of Herbalife in a report on Thursday. Finally, Mizuho set a $13.00 target price on Herbalife and gave the company a “neutral” rating in a research report on Thursday, January 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $16.60.

Herbalife Trading Up 1.8%

Shares of Herbalife stock opened at $19.92 on Friday. Herbalife Ltd has a 12 month low of $6.20 and a 12 month high of $20.34. The firm has a market cap of $2.06 billion, a P/E ratio of 9.05 and a beta of 0.84. The stock’s fifty day moving average price is $15.60 and its 200-day moving average price is $11.74.

Herbalife (NYSE:HLF) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.03). The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.24 billion. Herbalife had a net margin of 4.53% and a negative return on equity of 35.02%. Herbalife’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.36 earnings per share. Analysts forecast that Herbalife Ltd will post 1.57 earnings per share for the current year.

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.